Non-Hodgkin's Lymphoma
Showing NaN - NaN of 27
Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States
Terminated
- Acute Myeloid Leukemia
- +2 more
- Venetoclax
- AMG 176
-
Duarte, California
- +16 more
Dec 3, 2021
Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma
Completed
- Non-Hodgkin's Lymphoma
-
Los Angeles, California
- +3 more
Nov 24, 2020
Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)
Completed
- Non-Hodgkin's Lymphoma
- ibritumomab tiuxetan
- BEAM chemotherapy and autologous stem-cell transplantation
-
Scottsdale, Arizona
- +8 more
Aug 13, 2020
Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)
Completed
- Follicular Lymphoma
- +2 more
-
Burbank, California
- +11 more
Mar 26, 2019
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
- bendamustine
- +5 more
-
Tucson, Arizona
- +127 more
Jan 8, 2018
Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Canada, United States (CAT-8015 (Moxetumomab Pasudotox))
Completed
- Acute Lymphoblastic Leukemia
- Non-Hodgkin's Lymphoma
- CAT-8015 (Moxetumomab Pasudotox)
-
Los Angeles, California
- +4 more
Aug 28, 2017
Non-Hodgkin's Lymphoma Trial in Los Angeles (Doxorubicin, Rituxan, Cyclophosphamide, Vincristine and Prednisone)
Completed
- Non-Hodgkin's Lymphoma
- Doxorubicin, Rituxan, Cyclophosphamide, Vincristine and Prednisone
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
Jul 13, 2017
Non-Hodgkin's Lymphoma Trial in United States (AME-133v (LY2469298))
Completed
- Non-Hodgkin's Lymphoma
- AME-133v (LY2469298)
-
Birmingham, Alabama
- +10 more
Jan 5, 2016
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease Trial in United States
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
-
Los Angeles, California
- +19 more
Nov 20, 2015
Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)
Completed
- Non-Hodgkin's Lymphoma
- obinutuzumab (RO5072759)
- rituximab
-
Los angeles, California
- +70 more
Aug 15, 2014
Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Los Angeles (Noscapine)
Terminated
- Non-Hodgkin's Lymphoma
- Chronic Lymphocytic Leukemia
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Non-Hodgkin's Lymphoma, Burkitt Lymphoma, Primary Effusion Lymphomas Trial in Los Angeles (Pegylated Liposomal Doxorubicin
Terminated
- Non-Hodgkin's Lymphoma
- +2 more
- Pegylated Liposomal Doxorubicin (Doxil) and Rituximab
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Non-Hodgkin's Lymphoma Trial in Los Angeles (Elsamitrusin)
Completed
- Non-Hodgkin's Lymphoma
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
May 20, 2014
Non-Hodgkin's Lymphoma Trial in Australia, Canada, United States (bendamustine and rituximab)
Completed
- Non-Hodgkin's Lymphoma
- bendamustine and rituximab
-
Anchorage, Alaska
- +33 more
May 8, 2014
Non-Hodgkin's Lymphoma Trial in Canada, Puerto Rico, United States (Bendamustine HCl)
Completed
- Non-Hodgkin's Lymphoma
- Bendamustine HCl
-
Birmingham, Alabama
- +39 more
May 8, 2014
Non-Hodgkin's Lymphoma Trial in Worldwide (Bortezomib + Rituximab, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- Bortezomib + Rituximab
- Rituximab
-
Opelika,, Alabama
- +205 more
Jun 19, 2012
Non-Hodgkin's Lymphoma Trial in United States (Id-KLH)
Unknown status
- Non-Hodgkin's Lymphoma
- Id-KLH
-
La Jolla, California
- +14 more
Sep 29, 2009
Non-Hodgkin's Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine)
Terminated
- Non-Hodgkin's Lymphoma
- autologous immunoglobulin idiotype-KLH conjugate vaccine
-
Los Angeles, California
- +8 more
Mar 14, 2008